Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • diabetic retinopathy

    - PMLiVE

    Exhibition Trends 2026: What Pharma Exhibitors Need to Know Now

    Exhibitions remain one of the most powerful ways for pharmaceutical and life sciences organisations to connect, educate and build trust. Whether you're launching innovations, strengthening partnerships or showcasing research, the...

    Apex Events and Exhibitions

    - PMLiVE

    Europe Celebrates the Heart of Healthcare Decision-Making as Laboratory Medicine Professionals Take Centre Stage

    Today, the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) proudly marks European Laboratory Day, celebrating the professionals at the heart of healthcare decision making. Across Europe, laboratories will...

    EatMoreFruit

    Young girl receives vaccine jab in her arm

    Regaining trust in childhood vaccines: can better comms turn the tables on hesitancy and misinformation?

    In the wake of Trump questioning MMR vaccines, we review the best practices in vaccine communications and consider how to reverse damage done to public trust in childhood vaccinations.

    Say Communications

    - PMLiVE

    Shifting the Paradigm: A New Era for Parkinson’s Care

    In this episode of “Hear From Her:” Hear from two leaders at the forefront of a much-needed change in how Parkinson’s is understood, diagnosed, and treated.

    Medscape Education

    Reimagine health with Inizio.

    At Inizio, we provide tailored, innovative solutions to help health and life sciences companies with their clinical development and commercialization journeys, maximizing patient access. Our experts guide you through each...

    Inizio

    - PMLiVE

    UK government publishes 10 Year Health Plan for England to ‘reinvent’ NHS

    The plan’s three overarching themes are hospital to community, analogue to digital and sickness to prevention

    - PMLiVE

    Eli Lilly shares promising phase 3 results for once-weekly insulin candidate efsitora alfa

    The company is planning to submit regulatory applications for the candidate by the end of the year

    regeneron headquarters

    Regeneron gains rights to Hansoh’s GLP-1/GIP receptor agonist in deal worth $2bn

    The candidate is being evaluated in a phase 3 obesity trial and phase 2b diabetes study

    - PMLiVE

    30 Years of Innovation in Education at HLTH Europe

    The Medscape Education Global team will be travelling to Amsterdam for the HLTH Europe 2025 conference to showcase the power and value of CME. As pioneers in clinician education for...

    Medscape Education

    - PMLiVE

    A Sparkling Achievement: Sarah Atwood Celebrated as a 2024 CPD Forty Under 40

    For Sarah Atwood, MPH, the proudest moment of her incredible career in education and instructional design is happening right now. Atwood is an instructional designer with a public health lens...

    Medscape Education

    - PMLiVE

    Eli Lilly announces $3bn expansion to US injectables manufacturing facility

    The investment will help Lilly meeting the growing demand for its diabetes and obesity medicines

    - PMLiVE

    Sanofi unveils plans to build €1bn insulin production base in China

    The site will focus on serving the insulin medication needs of local diabetic patients

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links